J. Dockendorff Charles's Insider Trades & SAST Disclosures
J. Dockendorff Charles's most recent trade in Hologic, Inc. was a trade of 5,535 Non-qualified Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 26, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern J. Dockendorff Charles.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Hologic, Inc. | Charles J. Dockendorff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 5,535 | 5,535 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic, Inc. | Charles J. Dockendorff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 1,864 | 3,436 (0%) | 0% | - | Common Stock | |
| Haemonetics Corp. | Charles J. Dockendorff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2024 | 2,207 | 4,433 (0%) | 0% | - | Common Stock | |
| Boston Scientific Corp. | Charles J. Dockendorff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 2,901 | 2,901 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | Charles J. Dockendorff | Director | Sale of securities on an exchange or to another person at price $ 72.70 per share. | 07 May 2024 | 3,946 | 0 (0%) | 0% | 72.7 | 286,874 | Common Stock |
| Keysight Technologies Inc | Charles J. Dockendorff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2024 | 1,632 | 52,754 (0%) | 0% | 0 | Common Stock | |
| Hologic, Inc. | Charles J. Dockendorff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 4,536 | 4,536 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic, Inc. | Charles J. Dockendorff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 1,572 | 3,037 (0%) | 0% | - | Common Stock | |
| Hologic, Inc. | Charles J. Dockendorff | Director | Sale of securities on an exchange or to another person at price $ 76.21 per share. | 07 Mar 2024 | 1,465 | 1,572 (0%) | 0% | 76.2 | 111,648 | Common Stock |
| Hologic, Inc. | Charles J. Dockendorff | Director | Sale of securities on an exchange or to another person at price $ 72.00 per share. | 02 Jan 2024 | 16,017 | 1,465 (0%) | 0% | 72 | 1,153,224 | Common Stock |
| Hologic, Inc. | J. Dockendorff Charles | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2024 | 7,551 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic, Inc. | J. Dockendorff Charles | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.44 per share. | 02 Jan 2024 | 7,551 | 17,482 (0%) | 0% | 38.4 | 290,260 | Common Stock |
| Haemonetics Corp. | Charles J. Dockendorff | Director | Sale of securities on an exchange or to another person at price $ 87.68 per share. | 05 Sep 2023 | 10,215 | 2,226 (0%) | 0% | 87.7 | 895,651 | Common Stock |
| Boston Scientific Corp. | Charles J. Dockendorff | Director | Sale of securities on an exchange or to another person at price $ 50.74 per share. | 18 Aug 2023 | 17,079 | 3,946 (0%) | 0% | 50.7 | 866,631 | Common Stock |
| Haemonetics Corp. | Charles J. Dockendorff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2023 | 2,226 | 12,441 (0%) | 0% | - | Common Stock | |
| Boston Scientific Corp. | Charles J. Dockendorff | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 04 May 2023 | 8,201 | 0 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | Charles J. Dockendorff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 3,946 | 21,025 (0%) | 0% | 0 | Common Stock | |
| Keysight Technologies Inc | Charles J. Dockendorff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 1,543 | 51,122 (0%) | 0% | 0 | Common Stock | |
| Hologic, Inc. | Charles J. Dockendorff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 4,210 | 4,210 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic, Inc. | Charles J. Dockendorff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 1,465 | 6,725 (0%) | 0% | - | Common Stock | |
| Hologic, Inc. | Charles J. Dockendorff | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Feb 2023 | 1,336 | 0 (0%) | 0% | 0 | Common Stock | |
| Keysight Technologies Inc | Charles J. Dockendorff | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jan 2023 | 2,844 | 0 (0%) | 0% | 0 | Common Stock | |
| Keysight Technologies Inc | Charles J. Dockendorff | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Dec 2022 | 7,551 | 55,680 (0%) | 0% | 0 | Common Stock | |
| Keysight Technologies Inc | Charles J. Dockendorff | Director | Sale of securities on an exchange or to another person at price $ 185.06 per share. | 12 Dec 2022 | 3,257 | 52,423 (0%) | 0% | 185.1 | 602,753 | Common Stock |
| Haemonetics Corp. | Charles J. Dockendorff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2022 | 2,730 | 28,130 (0%) | 0% | - | Common Stock | |
| Boston Scientific Corp. | Charles J. Dockendorff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 4,877 | 17,079 (0%) | 0% | 0 | Common Stock | |
| Keysight Technologies Inc | Charles J. Dockendorff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2022 | 1,626 | 63,231 (0%) | 0% | 0 | Common Stock | |
| Hologic, Inc. | Charles J. Dockendorff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 5,293 | 5,293 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic, Inc. | Charles J. Dockendorff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 1,565 | 5,260 (0%) | 0% | - | Common Stock | |
| Keysight Technologies Inc | Charles J. Dockendorff | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Oct 2021 | 3,240 | 0 (0%) | 0% | 0 | Common Stock | |
| Haemonetics Corp. | Charles J. Dockendorff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2021 | 3,077 | 25,400 (0%) | 0% | - | Common Stock | |
| Boston Scientific Corp. | Charles J. Dockendorff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2021 | 4,763 | 37,062 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific Corp. | Charles J. Dockendorff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2021 | 2,439 | 39,501 (0%) | 0% | 0 | Common Stock | |
| Keysight Technologies Inc | Charles J. Dockendorff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2021 | 1,631 | 64,845 (0%) | 0% | 0 | Common Stock | |
| Hologic, Inc. | Charles J. Dockendorff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2021 | 5,055 | 5,055 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic, Inc. | Charles J. Dockendorff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2021 | 1,478 | 3,695 (0%) | 0% | - | Common Stock | |
| Haemonetics Corp. | Charles J. Dockendorff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2021 | 12,180 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Haemonetics Corp. | Charles J. Dockendorff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.50 per share. | 04 Feb 2021 | 12,180 | 25,935 (0%) | 0% | 35.5 | 432,420 | Common Stock |
| Haemonetics Corp. | Charles J. Dockendorff | Director | Sale of securities on an exchange or to another person at price $ 134.53 per share. | 04 Feb 2021 | 12,180 | 13,755 (0%) | 0% | 134.5 | 1,638,575 | Common Stock |
| Haemonetics Corp. | Charles J. Dockendorff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2020 | 1,983 | 13,755 (0%) | 0% | - | Common Stock | |
| Boston Scientific Corp. | Charles J. Dockendorff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2020 | 5,000 | 16,099 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges